Company intelligence / Profile preview

ABLi Therapeutics, Inc.

Atlanta, Georgia, USAabliva.com ↗
Ownership
Private
Employees
~5
Development stage
Phase 2
01

Overview

ABLi Therapeutics, Inc., based in Atlanta, GA, is a small biotechnology company focused on developing novel therapeutics primarily targeting neurodegenerative disorders such as multiple system atrophy and Parkinson’s disease as well as infectious diseases like progressive multifocal leukoencephalopathy caused by JC virus reactivation in immunocompromised patients such as those with AIDS. The company has received significant support through US government SBIR/STTR grants totaling over $13 million since its inception around or before 2009. Its pipeline includes preclinical to early clinical candidates involving kinase modulation and anti-infective strategies aimed at high unmet medical needs within neurology and infectious disease domains[1][4][8].

Therapeutic areas
NeurologyInfectious Diseases
Modalities
Small molecules (based on SBIR project descriptions for kinase inhibitors and anti-infectives)Potential biologics/other modalities not explicitly stated but possible given focus areas.
Industry
Biotech
02

Drug pipeline

1 asset

risvodetinib

2

Beyond the preview

Go deeper on ABLi Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABLi Therapeutics, Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call